Exact Mass: 287.0688

Exact Mass Matches: 287.0688

Found 76 metabolites which its exact mass value is equals to given mass value 287.0688, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tenofovir

({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid

C9H14N5O4P (287.0783)


Tenofovir is only found in individuals that have used or taken this drug. Tenofovir, marketed by Gilead Sciences under the trade name Viread®, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (nRTIs), which block reverse transcriptase, an enzyme crucial to viral production in HIV-infected people. [Wikipedia]Tenofovir inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5’-triphosphate and, after incorporation into DNA, by DNA chain termination. Specifically, the drugs are analogues of the naturally occurring deoxynucleotides needed to synthesize the viral DNA and they compete with the natural deoxynucleotides for incorporation into the growing viral DNA chain. However, unlike the natural deoxynucleotides substrates, NRTIs and NtRTIs (nucleoside/tide reverse transcriptase inhibitors) lack a 3-hydroxyl group on the deoxyribose moiety. As a result, following incorporation of an NRTI or an NtRTI, the next incoming deoxynucleotide cannot form the next 5-3 phosphodiester bond needed to extend the DNA chain. Thus, when an NRTI or NtRTI is incorporated, viral DNA synthesis is halted, a process known as chain termination. All NRTIs and NtRTIs are classified as competitive substrate inhibitors. C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Tenofovir (GS 1278) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV)[1].

   

Sulmazole

2-[2-Methoxy-4-(methylsulphinyl)phenyl]-3H-imidazo[4,5-b]pyridine

C14H13N3O2S (287.0728)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Cycloguanil Hydrochloride

Cycloguanil Hydrochloride

C11H15Cl2N5 (287.0704)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

Nodinitib-1

ML130 (Nodinitib-1)

C14H13N3O2S (287.0728)


   

(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide

(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide

C16H14ClNO2 (287.0713)


   

1-[Amino-(3,4-dichloroanilino)methylidene]-2-propan-2-ylguanidine

1-[N-(3,4-dichlorophenyl)carbamimidamido]-N-(propan-2-yl)methanimidamide

C11H15Cl2N5 (287.0704)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

6-Chloro-2',3'-dideoxyguanosine

2-amino-6-chloro-9-[5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-ol

C10H14ClN5O3 (287.0785)


   

9-(2-Phosphonomethoxypropyl)adenine

({[1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid

C9H14N5O4P (287.0783)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

Incadronic acid

Hydronium (cycloheptylammonio)methylene-1,1-bisphosphonate

C8H19NO6P2 (287.0688)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

Isomazole

2-((2-Methoxy-4-methylsulfinyl)phenyl)-H-imidazo(4,5-b)pyridine

C14H13N3O2S (287.0728)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

N-(3-Methoxyphenyl)-4-chlorocinnamanilide

3-(4-Chlorophenyl)-N-(3-methoxyphenyl)prop-2-enimidate

C16H14ClNO2 (287.0713)


   

[1-(Phenylsulfonyl)-1H-indol-2-yl]methanol

[1-(Phenylsulfonyl)-1H-indol-2-yl]methanol

C15H13NO3S (287.0616)


   
   
   
   
   

3-(4-chlorophenyl)-N-(3-methoxyphenyl)-2-propenamide

3-(4-chlorophenyl)-N-(3-methoxyphenyl)-2-propenamide

C16H14ClNO2 (287.0713)


   

Tenofovir

D,L-Tenofovir;PMPA;TDF;Tenofovir disoproxil;Tenofovir disoproxil fumarate

C9H14N5O4P (287.0783)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3105 Tenofovir (GS 1278) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV)[1].

   

SB-366791

N-(3-Methoxyphenyl)-4-chlorocinnamanilide

C16H14ClNO2 (287.0713)


   

4-(CYANOMETHYL)PHENYL 4-METHYLBENZENE-1-SULFONATE

4-(CYANOMETHYL)PHENYL 4-METHYLBENZENE-1-SULFONATE

C15H13NO3S (287.0616)


   

[1-(PHENYLSULFONYL)-1H-INDOL-3-YL]METHANOL

[1-(PHENYLSULFONYL)-1H-INDOL-3-YL]METHANOL

C15H13NO3S (287.0616)


   

3-Pyrrolidinecarboxylic acid, 5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]-

3-Pyrrolidinecarboxylic acid, 5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]-

C13H12F3NO3 (287.0769)


   

(4-cyano-3,5-difluorophenyl) 4-ethylbenzoate

(4-cyano-3,5-difluorophenyl) 4-ethylbenzoate

C16H11F2NO2 (287.0758)


   

2-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethanol

2-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethanol

C13H12F3NOS (287.0592)


   

Thionin acetate

Thionin acetate

C14H13N3O2S (287.0728)


D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides

   

2-(7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOL-3-YL)ACETIC ACID

2-(7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOL-3-YL)ACETIC ACID

C16H11F2NO2 (287.0758)


   

2-CHLORO-4,5,7,8-TETRAHYDRO-6H-THIENO[2,3-D]AZEPINE-6-CARBOXYLIC ACID, T-BUTYLESTER

2-CHLORO-4,5,7,8-TETRAHYDRO-6H-THIENO[2,3-D]AZEPINE-6-CARBOXYLIC ACID, T-BUTYLESTER

C13H18ClNO2S (287.0747)


   

ETHYL 7-METHYL-2-(2-THIENYL)PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE

ETHYL 7-METHYL-2-(2-THIENYL)PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE

C14H13N3O2S (287.0728)


   

3-(METHOXYCARBONYL)-1-(2-ETHOXYETHYL)-4-NITRO-1H-PYRAZOLE-5-CARBOXYLIC ACID

3-(METHOXYCARBONYL)-1-(2-ETHOXYETHYL)-4-NITRO-1H-PYRAZOLE-5-CARBOXYLIC ACID

C10H13N3O7 (287.0753)


   

Sodium 3-(1-naphthylamino)-1-propanesulfonate

Sodium 3-(1-naphthylamino)-1-propanesulfonate

C13H14NNaO3S (287.0592)


   

2-(BENZOYLAMINO)-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHENE-3-CARBOXYLIC ACID

2-(BENZOYLAMINO)-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHENE-3-CARBOXYLIC ACID

C15H13NO3S (287.0616)


   

1-(4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YL)ETHANOL

1-(4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YL)ETHANOL

C13H12F3NOS (287.0592)


   

3-ETHOXY-2-(2-NAPHTHYLSULFONYL)ACRYLONITRILE

3-ETHOXY-2-(2-NAPHTHYLSULFONYL)ACRYLONITRILE

C15H13NO3S (287.0616)


   

3-METHOXY-1-(PHENYLSULFONYL)-1H-INDOLE

3-METHOXY-1-(PHENYLSULFONYL)-1H-INDOLE

C15H13NO3S (287.0616)


   

2-(4-(ETHYLAMINO)PHENYL)-1,1,1,3,3,3-HEXAFLUOROPROPAN-2-OL

2-(4-(ETHYLAMINO)PHENYL)-1,1,1,3,3,3-HEXAFLUOROPROPAN-2-OL

C11H11F6NO (287.0745)


   

2-chloro-1-(3-phenyl-2,3-dihydro-1,4-benzoxazin-4-yl)ethanone

2-chloro-1-(3-phenyl-2,3-dihydro-1,4-benzoxazin-4-yl)ethanone

C16H14ClNO2 (287.0713)


   

1-(4-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOL-5-AMINE

1-(4-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOL-5-AMINE

C15H11ClFN3 (287.0625)


   

6-methoxy-1-(phenylsulfonyl)-1H-indole

6-methoxy-1-(phenylsulfonyl)-1H-indole

C15H13NO3S (287.0616)


   

(2Z)-3-(Acetylamino)-4-(2,4,5-trifluorophenyl)-2-butenoic acid methyl ester

(2Z)-3-(Acetylamino)-4-(2,4,5-trifluorophenyl)-2-butenoic acid methyl ester

C13H12F3NO3 (287.0769)


   

2,6-dichloro-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2,6-dichloro-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C12H16BCl2NO2 (287.0651)


   

2-chloro-6-(3-hydroxypropylamino)phenalen-1-one

2-chloro-6-(3-hydroxypropylamino)phenalen-1-one

C16H14ClNO2 (287.0713)


   

6-(2-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

6-(2-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

C16H14ClNO2 (287.0713)


   

6-(3-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

6-(3-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

C16H14ClNO2 (287.0713)


   

4-C-azido-2-deoxy-2-fluoro-beta-D-arabinouridine

4-C-azido-2-deoxy-2-fluoro-beta-D-arabinouridine

C9H10FN5O5 (287.0666)


   

4-C-azido-3-deoxy-3-fluoro-Uridine

4-C-azido-3-deoxy-3-fluoro-Uridine

C9H10FN5O5 (287.0666)


   

5-Carboxycytidine

5-Carboxycytidine

C10H13N3O7 (287.0753)


   

1-PHENYLSULFONYLINDOLE-5-METHANOL

1-PHENYLSULFONYLINDOLE-5-METHANOL

C15H13NO3S (287.0616)


   

3-PHENYL-2-(4,4,4-TRIFLUORO-3-OXO-BUT-1-ENYLAMINO)-PROPIONIC ACID

3-PHENYL-2-(4,4,4-TRIFLUORO-3-OXO-BUT-1-ENYLAMINO)-PROPIONIC ACID

C13H12F3NO3 (287.0769)


   

CP 93129 dihydrochloride

CP 93129 dihydrochloride

C12H15Cl2N3O (287.0592)


CP 93129 dihydrochloride is a potent 5HT1B receptor agonist. CP 93129 dihydrochloride has the potential for parkinson's disease research[1].

   

1-(benzenesulfonyl)-7-methoxyindole

1-(benzenesulfonyl)-7-methoxyindole

C15H13NO3S (287.0616)


   

6-(4-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

6-(4-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

C16H14ClNO2 (287.0713)


   

3-(6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-2-yl)benzonitrile

3-(6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-2-yl)benzonitrile

C15H8F3N3 (287.067)


   
   

Pentopyranic acid

Pentopyranic acid

C10H13N3O7 (287.0753)


   

3-(4-Chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-5-amine

3-(4-Chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-5-amine

C15H11ClFN3 (287.0625)


   

(3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-YL)-phosphoramidic acid dimethyl ester

(3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-YL)-phosphoramidic acid dimethyl ester

C8H18NO8P (287.077)


   

Incadronic

Incadronic acid

C8H19NO6P2 (287.0688)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide

(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide

C16H14ClNO2 (287.0713)


   

2-amino-6-chloro-9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-ol

2-amino-6-chloro-9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-ol

C10H14ClN5O3 (287.0785)


D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides

   

2-(2-furanyl)-6,7,8,9-tetrahydro-5H-cyclohepta[2,3]thieno[2,4-b][1,3]oxazin-4-one

2-(2-furanyl)-6,7,8,9-tetrahydro-5H-cyclohepta[2,3]thieno[2,4-b][1,3]oxazin-4-one

C15H13NO3S (287.0616)


   

5-(2,3-dihydro-1H-indol-1-ylmethylene)-1-methyl-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione

5-(2,3-dihydro-1H-indol-1-ylmethylene)-1-methyl-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione

C14H13N3O2S (287.0728)


   

6-[(4-Chloroanilino)methylidene]-3-prop-2-enoxy-1-cyclohexa-2,4-dienone

6-[(4-Chloroanilino)methylidene]-3-prop-2-enoxy-1-cyclohexa-2,4-dienone

C16H14ClNO2 (287.0713)


   

5-(1,3-dioxoisoindol-2-yl)-1H-indole-3-carbonitrile

5-(1,3-dioxoisoindol-2-yl)-1H-indole-3-carbonitrile

C17H9N3O2 (287.0695)


   

(2R)-2-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetamide

(2R)-2-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetamide

C10H13N3O7 (287.0753)


   

chlorproguanil

chlorproguanil

C11H15Cl2N5 (287.0704)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

sulmazole

sulmazole

C14H13N3O2S (287.0728)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Isomazole

Isomazole

C14H13N3O2S (287.0728)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

tenofovir (anhydrous)

tenofovir (anhydrous)

C9H14N5O4P (287.0783)


A member of the class of phosphonic acids that is methylphosphonic acid in which one of the methyl hydrogens is replaced by a [(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy group. An inhibitor of HIV-1 reverse transcriptase, the bis(isopropyloxycarbonyloxymethyl) ester (disoproxil ester) prodrug is used as the fumaric acid salt in combination therapy for the treatment of HIV infection.

   

cytosylglucuronic acid

cytosylglucuronic acid

C10H13N3O7 (287.0753)


An N-glycosyl compound that is cytosine in which the proton at position 1 is replaced by a beta-D-glucuronosyl residue.

   

(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid

C10H13N3O7 (287.0753)


   

amino[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid

amino[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid

C10H13N3O7 (287.0753)


   

4-ethenylphenyl 3-amino-4-hydroxy-2-sulfanylbenzoate

4-ethenylphenyl 3-amino-4-hydroxy-2-sulfanylbenzoate

C15H13NO3S (287.0616)


   

2-[4-(hydroxymethyl)-1,3-thiazol-2-yl]-4-methoxynaphthalen-1-ol

2-[4-(hydroxymethyl)-1,3-thiazol-2-yl]-4-methoxynaphthalen-1-ol

C15H13NO3S (287.0616)


   

3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid

3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid

C10H13N3O7 (287.0753)


   

3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol

3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol

C8H18NO8P (287.077)


   

(2r)-3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol

(2r)-3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol

C8H18NO8P (287.077)